VALORANT player profile · Europe region · Account level 236 · Title “Biohazard” · 0 profile views
Current rank: IRON 2 - 87 RR (as of last recorded competitive match, 2026-05-25).
Peak recorded rank: IRON 3 - 22 RR (reached 2026-05-17).
Ranks derive from recorded ranked matches; games played while untracked may not be reflected.
| Tracked matches | 61 |
|---|---|
| Win rate | 0.0% (0 W / 3 L over 3 matches with recorded stats) |
| K/D | 0.89 (42 kills / 47 deaths / 15 assists) |
| Average combat score | 186 |
| Headshot rate | 10.5% |
| Date | Mode | Map | Agent | Result | K/D/A | ACS | RR |
|---|---|---|---|---|---|---|---|
| 2026-05-27 | Unrated | Abyss | - | - | - | - | +0 |
| 2026-05-26 | Unrated | Corrode | - | - | - | - | +0 |
| 2026-05-25 | Competitive | Ascent | - | - | - | - | -13 |
| 2026-05-25 | Skirmish: Ascension 2v2 | Skirmish B | - | - | - | - | +0 |
| 2026-05-25 | Skirmish: Ascension 2v2 | Skirmish B | - | - | - | - | +0 |
| 2026-05-24 | Unrated | Breeze | - | - | - | - | +0 |
| 2026-05-24 | Skirmish: Ascension 2v2 | Skirmish C | - | - | - | - | +0 |
| 2026-05-23 | Unrated | Lotus | - | - | - | - | +0 |
| 2026-05-23 | Unrated | Bind | - | - | - | - | +0 |
| 2026-05-21 | Unrated | Fracture | Viper | L | 6/10/6 | 157 | - |
| 2026-05-19 | Skirmish: Ascension 2v2 | Skirmish A | - | - | - | - | +0 |
| 2026-05-19 | Skirmish: Ascension 2v2 | Skirmish A | - | - | - | - | +0 |
| 2026-05-17 | Competitive | Split | - | - | - | - | -30 |
| 2026-05-17 | Competitive | Fracture | Sage | L | 22/18/5 | 242 | -10 |
| 2026-05-17 | Competitive | Pearl | - | - | - | - | +12 |
| 2026-05-17 | Skirmish: Ascension 1v1 | Skirmish A | - | - | - | - | +0 |
| 2026-05-17 | Skirmish: Ascension 1v1 | Skirmish B | - | - | - | - | +0 |
| 2026-05-14 | Competitive | Haven | - | - | - | - | +21 |
| 2026-05-13 | Unrated | Corrode | Viper | L | 14/19/4 | 157 | - |
| 2026-05-03 | Skirmish: 2v2 | Skirmish A | - | - | - | - | +0 |
Showing 20 of 61 tracked matches. The interactive profile lists all of them.
No penalty records for this player.